Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
225.79
-2.95 (-1.29%)
Feb 21, 2025, 4:00 PM EST - Market closed
Veeva Systems Revenue
Veeva Systems had revenue of $699.21M in the quarter ending October 31, 2024, with 13.41% growth. This brings the company's revenue in the last twelve months to $2.66B, up 15.67% year-over-year. In the fiscal year ending January 31, 2024, Veeva Systems had annual revenue of $2.36B with 9.68% growth.
Revenue (ttm)
$2.66B
Revenue Growth
+15.67%
P/S Ratio
13.73
Revenue / Employee
$370,378
Employees
7,172
Market Cap
36.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2024 | 2.36B | 208.61M | 9.68% |
| Jan 31, 2023 | 2.16B | 304.28M | 16.44% |
| Jan 31, 2022 | 1.85B | 385.71M | 26.33% |
| Jan 31, 2021 | 1.47B | 360.99M | 32.70% |
| Jan 31, 2020 | 1.10B | 241.87M | 28.05% |
| Jan 31, 2019 | Pro | Pro | Pro |
| Jan 31, 2018 | Pro | Pro | Pro |
| Jan 31, 2017 | Pro | Pro | Pro |
| Jan 31, 2016 | Pro | Pro | Pro |
| Jan 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
VEEV News
- 3 days ago - Compliance Group Joins Veeva Services Partner Program to Deliver Implementation Support, Validation, and Post-Implementation Support Services - Business Wire
- 9 days ago - Veeva to Release Fiscal 2025 Fourth Quarter and Full Year Results on March 5, 2025 - PRNewsWire
- 19 days ago - DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration - Business Wire
- 24 days ago - More Than 200 Companies Advance Trial Management with Veeva CTMS - PRNewsWire
- 25 days ago - Veeva Systems: Forget The Short-Term Volatility; The Long Term Is Promising - Seeking Alpha
- 4 weeks ago - Veeva and Zifo Partner to Accelerate Quality Control Modernization - PRNewsWire
- 5 weeks ago - Veeva to Present at Upcoming Investor Conference - PRNewsWire
- 6 weeks ago - Veeva's Vault Is Safe-But What About Its CRM Offering - Seeking Alpha